113 related articles for article (PubMed ID: 11311752)
1. Synthesis and stereoselective kappa-receptor binding of methylated analogues of GR-89.696.
Röhr C; Soukara S; Wünsch B
Eur J Med Chem; 2001 Feb; 36(2):211-4. PubMed ID: 11311752
[TBL] [Abstract][Full Text] [Related]
2. Methylated analogues of methyl (R)-4-(3,4-dichlorophenylacetyl)- 3-(pyrrolidin-1-ylmethyl)piperazine-1-carboxylate (GR-89,696) as highly potent kappa-receptor agonists: stereoselective synthesis, opioid-receptor affinity, receptor selectivity, and functional studies.
Soukara S; Maier CA; Predoiu U; Ehret A; Jackisch R; Wünsch B
J Med Chem; 2001 Aug; 44(17):2814-26. PubMed ID: 11495592
[TBL] [Abstract][Full Text] [Related]
3. [(11)C]-GR89696, a potent kappa opiate receptor radioligand; in vivo binding of the R and S enantiomers.
Ravert HT; Scheffel U; Mathews WB; Musachio JL; Dannals RF
Nucl Med Biol; 2002 Jan; 29(1):47-53. PubMed ID: 11786275
[TBL] [Abstract][Full Text] [Related]
4. Stereoselective synthesis and structure-affinity relationships of bicyclic kappa receptor agonists.
Kracht D; Rack E; Schepmann D; Fröhlich R; Wünsch B
Org Biomol Chem; 2010 Jan; 8(1):212-25. PubMed ID: 20024152
[TBL] [Abstract][Full Text] [Related]
5. Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. Part 2: 8-formamidocyclazocine analogues.
Wentland MP; Sun X; Ye Y; Lou R; Bidlack JM
Bioorg Med Chem Lett; 2003 Jun; 13(11):1911-4. PubMed ID: 12749896
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and structure-opioid activity relationships of trans-(+/-)-3,4-dichloro-N-methyl-N-[4- or 5-hydroxy-2-(1-pyrrolidiny)cyclohexyl]benzeneacetamides.
Cheng CY; Chen CY; Tao PL
J Pharm Pharmacol; 1997 Sep; 49(9):835-42. PubMed ID: 9306249
[TBL] [Abstract][Full Text] [Related]
7. Probes for narcotic receptor mediated phenomena. 23. Synthesis, opioid receptor binding, and bioassay of the highly selective delta agonist (+)-4-[(alpha R)-alpha-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]- N,N-diethylbenzamide (SNC 80) and related novel nonpeptide delta opioid receptor ligands.
Calderon SN; Rice KC; Rothman RB; Porreca F; Flippen-Anderson JL; Kayakiri H; Xu H; Becketts K; Smith LE; Bilsky EJ; Davis P; Horvath R
J Med Chem; 1997 Feb; 40(5):695-704. PubMed ID: 9057856
[TBL] [Abstract][Full Text] [Related]
8. Conformationally constrained kappa receptor agonists: stereoselective synthesis and pharmacological evaluation of 6,8-diazabicyclo[3.2.2]nonane derivatives.
Geiger C; Zelenka C; Lehmkuhl K; Schepmann D; Englberger W; Wünsch B
J Med Chem; 2010 May; 53(10):4212-22. PubMed ID: 20441176
[TBL] [Abstract][Full Text] [Related]
9. kappa-Opioid activity of the four stereoisomers of the peripherally selective kappa-agonists, EMD 60,400 and EMD 61,753.
Gottschlich R; Krug M; Barber A; Devant RM
Chirality; 1994; 6(8):685-9. PubMed ID: 7857777
[TBL] [Abstract][Full Text] [Related]
10. Factors influencing agonist potency and selectivity for the opioid delta receptor are revealed in structure-activity relationship studies of the 4-[(N-substituted-4-piperidinyl)arylamino]-N,N-diethylbenzamides.
Thomas JB; Herault XM; Rothman RB; Atkinson RN; Burgess JP; Mascarella SW; Dersch CM; Xu H; Flippen-Anderson JL; George CF; Carroll FI
J Med Chem; 2001 Mar; 44(6):972-87. PubMed ID: 11300879
[TBL] [Abstract][Full Text] [Related]
11. DPI-3290 [(+)-3-((alpha-R)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-hydroxybenzyl)-N-(3-fluorophenyl)-N-methylbenzamide]. I. A mixed opioid agonist with potent antinociceptive activity.
Gengo PJ; Pettit HO; O'Neill SJ; Wei K; McNutt R; Bishop MJ; Chang KJ
J Pharmacol Exp Ther; 2003 Dec; 307(3):1221-6. PubMed ID: 14534368
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and opioid-receptor binding of novel amino-substituted morphan analogues.
Höfner G; Streicher B; Wünsch B
Arch Pharm (Weinheim); 2001 Sep; 334(8-9):284-90. PubMed ID: 11688139
[TBL] [Abstract][Full Text] [Related]
13. Conformationally restricted κ-opioid receptor agonists: Synthesis and pharmacological evaluation of diastereoisomeric and enantiomeric decahydroquinoxalines.
Molenveld P; Bouzanne des Mazery R; Sterk GJ; Storcken RP; Autar R; van Oss B; van der Haas RN; Fröhlich R; Schepmann D; Wünsch B; Soeberdt M
Bioorg Med Chem Lett; 2015 Nov; 25(22):5326-30. PubMed ID: 26411794
[TBL] [Abstract][Full Text] [Related]
14. 8-Carboxamidocyclazocine analogues: redefining the structure-activity relationships of 2,6-methano-3-benzazocines.
Wentland MP; Lou R; Ye Y; Cohen DJ; Richardson GP; Bidlack JM
Bioorg Med Chem Lett; 2001 Mar; 11(5):623-6. PubMed ID: 11266156
[TBL] [Abstract][Full Text] [Related]
15. Probes for narcotic receptor mediated phenomena. 17. Synthesis and evaluation of a series of trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]benzeneacet amide (U50,488) related isothiocyanate derivatives as opioid receptor affinity ligands.
de Costa BR; Rothman RB; Bykov V; Band L; Pert A; Jacobson AE; Rice KC
J Med Chem; 1990 Apr; 33(4):1171-6. PubMed ID: 2157008
[TBL] [Abstract][Full Text] [Related]
16. alpha(2) Adrenoceptor agonists as potential analgesic agents. 2. Discovery of 4-(4-Imidazo)-1,3-dimethyl-6,7-dihydrothianaphthene [corrected] as a high-affinity ligand for the alpha(2D) adrenergic receptor.
Ross TM; Jetter MC; McDonnell ME; Boyd RE; Connelly CD; Martinez RP; Lewis MA; Codd EE; Raffa RB; Reitz AB
J Med Chem; 2000 Mar; 43(5):765-8. PubMed ID: 10715142
[No Abstract] [Full Text] [Related]
17. Probes for narcotic receptor-mediated phenomena. 25. Synthesis and evaluation of N-alkyl-substituted (alpha-piperazinylbenzyl)benzamides as novel, highly selective delta opioid receptor agonists.
Katsura Y; Zhang X; Homma K; Rice KC; Calderon SN; Rothman RB; Yamamura HI; Davis P; Flippen-Anderson JL; Xu H; Becketts K; Foltz EJ; Porreca F
J Med Chem; 1997 Aug; 40(18):2936-47. PubMed ID: 9288176
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
[TBL] [Abstract][Full Text] [Related]
19. Species differences in the stereoselectivity of kappa opioid binding sites for [3H]U-69593 and [3H]ethylketocyclazocine.
Benyhe S; Szücs M; Borsodi A; Wollemann M
Life Sci; 1992; 51(21):1647-55. PubMed ID: 1331638
[TBL] [Abstract][Full Text] [Related]
20. A potent new class of kappa-receptor agonist: 4-substituted 1-(arylacetyl)-2-[(dialkylamino)methyl]piperazines.
Naylor A; Judd DB; Lloyd JE; Scopes DI; Hayes AG; Birch PJ
J Med Chem; 1993 Jul; 36(15):2075-83. PubMed ID: 8393489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
